CYP7B1 and diabetes mellitus: In diabetes and NAFLD (Biddinger et al., 2008; Chen et al., 2016), reduced hepatic CYP7B1 expression has been reported, suggesting a role of the alternative pathway for metabolic homeostasis in humans.